Publicacions en què col·labora amb Julio García Suárez (18)

2002

  1. Apoptotic rate: A new indicator for the quantification of the incidence of apoptosis in cell cultures

    Cytometry, Vol. 48, Núm. 4, pp. 185-193

2000

  1. HCV-associated thrombocytopenia: Clinical characteristics and platelet response after recombinant α2b-interferon therapy

    British Journal of Haematology, Vol. 110, Núm. 1, pp. 98-103

1998

  1. Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukemia patients

    American Journal of Hematology, Vol. 57, Núm. 2, pp. 93-100

1997

  1. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia

    European Journal of Haematology, Vol. 59, Núm. 2, pp. 89-99

  2. Apoptosis y enfermedad (II): Enfermedades asociadas con exceso de apoptosis

    Inflamacion y Regulacion del Crecimiento Celular, Vol. 8, Núm. 1, pp. 17-25

  3. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities

    American Journal of Hematology, Vol. 55, Núm. 4, pp. 175-182

1996

  1. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma

    Experimental Hematology, Vol. 24, Núm. 1, pp. 26-30

1995

  1. Abnormal γIFN and αTNF secretion in purified CD2+ cells from autoimmune thrombocytopenic purpura (ATP) patients: Their implication in the clinical course of the disease

    American Journal of Hematology, Vol. 49, Núm. 4, pp. 271-276

  2. PERSISTENT LYMPHOCYTOSIS OF NATURAL KILLER CELLS AFTER SPLENECTOMY

    British Journal of Haematology

  3. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy

    British Journal of Haematology, Vol. 89, Núm. 3, pp. 653-655

1994

  1. About itp

    American Journal of Hematology

  2. Increased expression of CD56 and HLA/DR antigens in CD2+ cells from multiple myeloma patients

    American Journal of Hematology

  3. Natural killer cell numbers and activity in patients with chronic autoimmune thrombocytopenic purpura [2]

    Blood

1993

  1. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals

    Experimental Hematology, Vol. 21, Núm. 12, pp. 1563-1569

  2. Heterogeneous proliferative effect of tumor necrosis factor‐α and lymphotoxin on mitogen‐activated B cells from B‐chronic lymphocytic leukemia

    American Journal of Hematology, Vol. 43, Núm. 2, pp. 81-85

  3. Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset

    Blood, Vol. 82, Núm. 5, pp. 1538-1545

  4. T lymphocytes from autoimmune thrombocytopenic purpura show a defective activation and proliferation after cytoplasmic membrane and intracytoplasmic mitogenic signals

    American Journal of Hematology, Vol. 44, Núm. 1, pp. 1-8

  5. The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency

    British Journal of Haematology, Vol. 84, Núm. 3, pp. 464-470